CN111329621A - Transcatheter aortic prosthetic valve, delivery system and delivery method - Google Patents
Transcatheter aortic prosthetic valve, delivery system and delivery method Download PDFInfo
- Publication number
- CN111329621A CN111329621A CN201910682854.5A CN201910682854A CN111329621A CN 111329621 A CN111329621 A CN 111329621A CN 201910682854 A CN201910682854 A CN 201910682854A CN 111329621 A CN111329621 A CN 111329621A
- Authority
- CN
- China
- Prior art keywords
- aortic
- valve
- stent
- sheath
- prosthetic valve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Prostheses (AREA)
Abstract
Description
技术领域technical field
本发明涉及人工瓣膜技术领域,具体涉及一种经导管主动脉人工瓣膜、输送系统及输送方法。The invention relates to the technical field of artificial valves, in particular to a transcatheter aortic artificial valve, a delivery system and a delivery method.
背景技术Background technique
心脏主动脉瓣狭窄或关闭不全是临床常见的心血管疾病,并且随着人口老龄化其发病率不断升高,其中65岁以上人群中主动脉瓣狭窄的发病率达2%-7%。主动脉瓣关闭不全的发病率随人种不同而有区别,其发病率约为4.9-10%,并且随年龄增长而明显增加。对这些患者,临床上需要进行人工瓣膜置换以取代自身病变瓣膜。传统的心脏外科主动脉瓣膜置换术(Surgical Aortic Valve Replacement,SAVR)需要外科开胸,并在全身麻醉和体外循环辅助下进行。鉴于SAVR手术的高创伤性,其在高龄、合并症复杂、外科手术禁忌或者高危风险的主动脉瓣病变患者中应用受限。近年来,随着经导管主动脉瓣置换术(Transcatheter Aortic Valve Replacement,TAVR)的发展,微创介入治疗主动脉瓣病变获得良好的疗效,并且大幅降低了患者的手术风险。TAVR经过十几年的发展,在欧美已有超过40万名患者接受此技术的治疗。Aortic valve stenosis or insufficiency of the heart is a common clinical cardiovascular disease, and its incidence is increasing with the aging of the population. The incidence of aortic valve stenosis in people over 65 years old is 2%-7%. The incidence of aortic insufficiency varies with ethnicity, and its incidence is about 4.9-10%, and it increases significantly with age. For these patients, prosthetic valve replacement is clinically required to replace the native diseased valve. Traditional cardiac surgery for aortic valve replacement (Surgical Aortic Valve Replacement, SAVR) requires surgical thoracotomy and is performed under general anesthesia and cardiopulmonary bypass. Given the highly invasive nature of SAVR, its use in patients with aortic valve disease who are elderly, have complex comorbidities, surgical contraindications, or are at high risk is limited. In recent years, with the development of Transcatheter Aortic Valve Replacement (TAVR), minimally invasive interventional treatment of aortic valve disease has achieved good curative effect and greatly reduced the surgical risk of patients. After more than ten years of development of TAVR, more than 400,000 patients in Europe and the United States have been treated with this technology.
随着TAVR技术的日趋成熟,涌现出多种类型和不同机制的经导管人工瓣膜系统,其中具有代表性的人工瓣膜系统包括:(欧美)爱德华的Sapien系列、美敦力的CoreValve系列,波科的Lotus系列和ACURATE系列等;以及(中国)杭州启明的VENUS系列和苏州杰成的J-VALVE系列等等。目前临床应用的各类型瓣膜各有优缺点,但在瓣膜植入的准确定位、位置调整、防止移位,以及兼顾狭窄和关闭不全病变等诸多方面还存在不足。其中,人工瓣膜的准确定位是临床推广应用的一个主要障碍。目前的人工瓣膜释放几乎均采用从左心室流出道到升主动脉的顺序进行,这导致瓣膜支架定位困难,临床上主要依靠术者经验进行操作,因此时常会造成瓣膜支架位置不佳。另外,临床上主动脉瓣狭窄常常合并关闭不全,而目前多数人工瓣膜是针对狭窄病变设计,无法应用于关闭不全患者;少数为关闭不全设计的人工瓣膜,又难以应用于狭窄性病变。临床上也迫切需要一种新型瓣膜系统能够兼顾主动脉瓣狭窄和关闭不全病变。With the maturity of TAVR technology, various types and different mechanisms of transcatheter prosthetic valve systems have emerged. Representative prosthetic valve systems include: (Europe and America) Edward's Sapien series, Medtronic's CoreValve series, Poco's Lotus series series and ACURATE series; and (China) Hangzhou Qiming's VENUS series and Suzhou Jiecheng's J-VALVE series and so on. At present, various types of valves in clinical application have their own advantages and disadvantages, but there are still shortcomings in many aspects such as accurate positioning, position adjustment, prevention of displacement, and consideration of stenosis and insufficiency of valve implantation. Among them, the accurate positioning of the artificial valve is a major obstacle to clinical application. The current prosthetic valve release is almost always performed sequentially from the left ventricular outflow tract to the ascending aorta, which makes the positioning of the valve stent difficult. In addition, clinical aortic valve stenosis is often combined with insufficiency, and most of the current artificial valves are designed for stenotic lesions and cannot be used in patients with insufficiency; a few artificial valves designed for insufficiency are difficult to apply to stenotic lesions. There is also an urgent need for a new valve system that can take into account both aortic stenosis and regurgitation.
因此,目前亟需一种全新的经导管主动脉人工瓣膜、输送系统及输送方法来解决上述问题。Therefore, there is an urgent need for a new transcatheter aortic prosthetic valve, delivery system and delivery method to solve the above problems.
发明内容SUMMARY OF THE INVENTION
为了解决现有经导管主动脉瓣置换术中的上述问题,即为了解决人工瓣膜植入的准确定位、位置调整、防止瓣膜移位并兼顾狭窄和关闭不全病变等技术难题。本发明的第一方面,提供了一种经导管主动脉人工瓣膜,包括呈网格状并且径向能够压缩和展开的支架以及安装在所述支架内侧的人工瓣叶,所述支架具有流入端和流出端,在所述支架的流出端设置有个多个向外张开并向下弯曲形成半环状倒钩的固定部,所述固定部一端连接所述支架,另一端朝向所述流入端的自由端方向。In order to solve the above problems in the existing transcatheter aortic valve replacement, that is, to solve the technical problems such as accurate positioning, position adjustment, prevention of valve displacement, and stenosis and insufficiency of artificial valve implantation. A first aspect of the present invention provides a transcatheter aortic prosthetic valve, comprising a grid-shaped stent capable of radially compressing and expanding, and a prosthetic valve leaflet installed inside the stent, the stent having an inflow end and the outflow end, at the outflow end of the bracket, there are a plurality of fixing parts that are opened outward and bent downward to form semi-annular barbs, one end of the fixing part is connected to the bracket, and the other end faces the inflow free end direction of the end.
在一些实施例中,在所述支架的流出端还设置有多个调整部,所述调整部一端连接所述支架,另一端向外张开并向下弯曲呈倒钩状指向所述支架外侧壁,或者向外并向上张开。In some embodiments, a plurality of adjustment parts are further provided at the outflow end of the bracket, one end of the adjustment parts is connected to the bracket, and the other end is opened outward and bent downward in a barb shape pointing to the outside of the bracket wall, or flare out and up.
在一些实施例中,所述固定部和所述调整部均为等间隔设置。In some embodiments, the fixing portion and the adjusting portion are arranged at equal intervals.
在一些实施例中,所述固定部和调整部的数量相等,所述固定部与所述支架形成封闭的第一网格孔,所述调整部与所述支架形成封闭的第二网格孔,所述第二网格孔位于所述第一网格孔之内。In some embodiments, the number of the fixing portion and the adjusting portion is equal, the fixing portion and the bracket form a closed first mesh hole, and the adjusting portion and the bracket form a closed second mesh hole , the second mesh hole is located inside the first mesh hole.
在一些实施例中,所述调整部上设置有连接件,用以连接输送系统的调整线缆。In some embodiments, the adjusting part is provided with a connecting piece for connecting the adjusting cable of the conveying system.
在一些实施例中,所述连接件为螺纹孔,可与所述调整线缆螺接;或者所述连接件为锁扣头,可与所述调整线缆上的锁扣槽进行锁扣;或者所述连接件为锁扣槽,可与所述调整线缆上的锁扣头进行锁扣。In some embodiments, the connecting member is a threaded hole, which can be screwed with the adjusting cable; or the connecting member is a locking head, which can be locked with a locking groove on the adjusting cable; Or the connecting piece is a locking groove, which can be locked with the locking head on the adjusting cable.
在一些实施例中,所述流出端横向设置有12个菱形网格,从而形成12个顶点,每4个连续的所述顶点形成一个连接区域,每个所述连接区域内最外侧的两个所述顶点分别连接同一所述固定部,每个所述连接区域内最内侧的两个所述顶点分别连接同一所述调整部。In some embodiments, the outflow end is laterally provided with 12 diamond meshes, thereby forming 12 vertices, every 4 consecutive vertices form a connection area, and the outermost two in each connection area The vertices are respectively connected to the same fixing part, and the two innermost vertices in each of the connecting regions are respectively connected to the same adjusting part.
在一些实施例中,所述支架为基于形状记忆合金和/或超弹性合金材料进行激光切割或编制而成。In some embodiments, the stent is laser cut or woven based on shape memory alloy and/or superelastic alloy material.
本发明的第二方面,还提供了一种输送系统,用于受试者心脏主动脉瓣膜的置换,所述系统包括可插入所述受试者主动脉内部的输送管鞘、设置在所述输送管鞘远端的容纳管鞘以及如上述的经导管主动脉人工瓣膜;In a second aspect of the present invention, there is also provided a delivery system for the replacement of aortic valve of a subject's heart, the system comprising a delivery catheter sheath insertable into the aorta of the subject, disposed in the aorta of the subject A receiving sheath at the distal end of the delivery sheath and a transcatheter aortic prosthetic valve as described above;
其中,所述经导管主动脉人工瓣膜处于压缩状态,所述经导管主动脉人工瓣膜的所述固定部和调整部置于所述输送管鞘远端的管鞘内,所述经导管主动脉人工瓣膜的其余部分置于所述容纳管鞘内。Wherein, the transcatheter aortic prosthetic valve is in a compressed state, the fixing part and the adjusting part of the transcatheter aortic prosthetic valve are placed in the sheath at the distal end of the delivery sheath, and the transcatheter aortic valve is in a compressed state. The remainder of the prosthetic valve is placed within the containment sheath.
本发明的第三方面,还提供了一种输送方法,用于受试者的心脏主动脉瓣膜的置换,所述输送方法包括:In a third aspect of the present invention, there is also provided a delivery method for the replacement of a heart aortic valve of a subject, the delivery method comprising:
提供一如上述的输送系统;provide a delivery system as described above;
基于所述输送管鞘穿经所述受试者的外周动脉,将所述容纳管鞘输送至主动脉瓣环以下,从而进入左心室流出道;delivering the containment sheath below the aortic annulus to enter the left ventricular outflow tract based on the passage of the delivery sheath through the peripheral artery of the subject;
固定所述容纳管鞘并后撤所述输送鞘管,释放所述固定部和调整部,使所述固定部向外张开并形成半环状倒钩进入主动脉窦;Fixing the accommodating tube sheath and withdrawing the delivery sheath tube, releasing the fixing part and the adjusting part, so that the fixing part expands outward and forms a semi-annular barb into the aortic sinus;
固定所述输送鞘管和调整线缆,前移所述容纳管鞘并释放所述支架,使所述支架展开固定在原位主动脉瓣膜区;Fixing the delivery sheath and adjusting the cable, moving the accommodating sheath forward and releasing the stent, so that the stent is deployed and fixed in the in-situ aortic valve area;
进一步释放所述调整部,使所述调整部张开形成指向瓣膜支架外侧壁的倒钩以进一步夹持固定原位主动脉瓣。The adjusting portion is further released, so that the adjusting portion is expanded to form a barb pointing to the outer side wall of the valve stent to further clamp and fix the in-situ aortic valve.
本发明提供的经导管主动脉人工瓣膜、输送系统及输送方法至少具有如下有益效果:The transcatheter aortic prosthetic valve, delivery system and delivery method provided by the present invention at least have the following beneficial effects:
在人工瓣膜支架的流出端设置多个向外张开并形成半环状倒钩的固定部,从而将固定部定位在主动脉窦内,实现了人工瓣膜的精准定位和释放,提高经导管心脏主动脉瓣膜置换术的安全性。The outflow end of the prosthetic valve stent is provided with a plurality of fixing parts that open outward and form semi-annular barbs, so as to locate the fixing parts in the aortic sinus, realize the precise positioning and release of the artificial valve, and improve the transcatheter heart rate. Safety of aortic valve replacement surgery.
进一步地,在支架的流出端设置多个调整部,基于调整部可以对瓣膜支架进行微调,进一步地提高定位的精度,调整部完全释放后呈向外张开并下弯曲呈倒钩状,末端指向瓣膜支架外侧壁以夹持原位主动脉瓣,防止人工瓣膜移位。Further, a plurality of adjustment parts are arranged at the outflow end of the stent, and the valve stent can be fine-tuned based on the adjustment parts, which further improves the positioning accuracy. Point to the lateral wall of the valve stent to hold the in situ aortic valve and prevent the prosthetic valve from shifting.
进一步地,本发明提供的输送方法中,在释放支架之前,先释放流出端的定位部,从而固定并准确定位在主动脉窦内;待定位准确后,再固定输送管鞘和调整线缆并前移容纳管鞘进而准确释放支架,使支架张开并与固定部和调整部共同夹持原位主动脉瓣膜从而进一步地稳定瓣膜支架。基于本发明的上述步骤可以大大降低经导管心脏主动脉瓣膜置换术的复杂程度,提高经导管心脏主动脉瓣膜置换术的成功率。Further, in the delivery method provided by the present invention, before releasing the stent, first release the positioning part of the outflow end, so as to fix and accurately position it in the aortic sinus; The accommodating tube sheath is moved to release the stent accurately, so that the stent is expanded and the in-situ aortic valve is clamped together with the fixing part and the adjusting part to further stabilize the valve stent. Based on the above steps of the present invention, the complexity of transcatheter aortic valve replacement can be greatly reduced, and the success rate of transcatheter aortic valve replacement can be improved.
附图说明Description of drawings
图1是本发明实施例中的一种经导管主动脉人工瓣膜的立体结构示意图;1 is a schematic three-dimensional structure diagram of a transcatheter aortic prosthetic valve according to an embodiment of the present invention;
图2是本发明实施例中的一种经导管主动脉人工瓣膜的俯视示意图;2 is a schematic top view of a transcatheter aortic prosthetic valve in an embodiment of the present invention;
图3是本发明实施例中的一种经导管主动脉人工瓣膜调整线缆释放前的主要结构示意图;3 is a schematic diagram of the main structure before the release of a transcatheter aortic prosthetic valve adjustment cable according to an embodiment of the present invention;
图4是本发明实施例中的一种经导管主动脉人工瓣膜支架剖开的平铺状态示意图;Fig. 4 is a kind of transcatheter aortic prosthetic valve stent in the embodiment of the present invention cut open and laying state schematic diagram;
图5是本发明实施例中的一种经导管主动脉人工瓣膜输送系统的主要结构示意图;5 is a schematic diagram of the main structure of a transcatheter aortic prosthetic valve delivery system according to an embodiment of the present invention;
图6是本发明实施例中的一种经导管主动脉人工瓣膜输送系统释放支架固定部的使用状态示意图;6 is a schematic diagram of a state of use of a transcatheter aortic prosthetic valve delivery system releasing a stent fixing part in an embodiment of the present invention;
图7是本发明实施例中的一种经导管主动脉人工瓣膜输送系统释放瓣膜支架部的使用状态示意图;7 is a schematic diagram of a state of use of a transcatheter aortic prosthetic valve delivery system to release a valve stent in an embodiment of the present invention;
图8是本发明实施例中的一种经导管主动脉人工瓣膜输送系统调整部与调整线缆解脱,完全释放人工瓣膜的使用状态示意图;8 is a schematic diagram of the use state of a transcatheter aortic prosthetic valve delivery system in which the adjustment part and the adjustment cable are disengaged and the artificial valve is completely released according to an embodiment of the present invention;
图9是本发明实施例中的一种经导管主动脉人工瓣膜输送方法的流程示意图之一;9 is one of the schematic flow charts of a method for delivering a transcatheter aortic prosthetic valve according to an embodiment of the present invention;
图10是本发明实施例中的一种经导管主动脉人工瓣膜输送方法的流程示意图之二;10 is the second schematic flow chart of a method for delivering a transcatheter aortic prosthetic valve according to an embodiment of the present invention;
图11是本发明实施例中的一种经导管主动脉人工瓣膜输送方法的流程示意图之三;11 is a third schematic flow chart of a method for delivering a transcatheter aortic prosthetic valve according to an embodiment of the present invention;
图12是本发明实施例中的一种经导管主动脉人工瓣膜输送方法的流程示意图之四。12 is a fourth schematic flowchart of a method for delivering a transcatheter aortic prosthetic valve according to an embodiment of the present invention.
具体实施方式Detailed ways
下面参照附图来描述本发明的优选实施方式。本领域技术人员应当理解的是,这些实施方式仅仅用于解释本发明的技术原理,并非旨在限制本发明的保护范围。Preferred embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood by those skilled in the art that these embodiments are only used to explain the technical principle of the present invention, and are not intended to limit the protection scope of the present invention.
参阅附图1至图3,图1至图3示例性示出了经导管主动脉人工瓣膜的主要结构,如图所示,经导管主动脉人工瓣膜包括呈网格状并且径向能够压缩和展开的支架1以及安装在支架1内侧的人工瓣叶2和衬裙3,支架1可以为基于形状记忆合金和/或超弹性合金材料进行激光切割或编制而成。人工瓣叶2安装在支架1内侧的腰部位置,并且可单向的开合,以形成血液由左心室进入主动脉的血液通道,人工瓣叶2可以两个、三个及其以上数量。人工瓣叶2的材料可以是动物心包膜,例如牛心包、猪心包等,或高分子材料,例如聚四氟乙烯、纤维布或纤维膜等,也可以使医用金属、热解碳等,人工瓣叶2还以是其它心脏瓣膜的可替代材料。安装在支架2内侧的衬裙3,用以增加密闭性能,衬裙3的材料可以是动物心包膜,例如牛心包、猪心包等,或高分子材料,例如聚四氟乙烯、纤维布或纤维膜等。在一些实施例中,人工瓣膜可以不包含衬裙。前述的人工瓣叶2和衬裙3的材料及安装均为现有技术,在此不再赘述,本发明提供的经导管主动脉人工瓣膜主要特点在于:Referring to Figures 1 to 3, Figures 1 to 3 exemplarily show the main structure of the transcatheter aortic prosthetic valve, as shown, the transcatheter aortic prosthetic valve includes a grid-like and radially compressible and The deployed
支架具有流入端4和流出端5,在支架1的流出端5设置有多个向外张开并向下弯曲形成半环状倒钩的固定部6,固定部6一端连接支架1,另一端朝向流入端4的自由端方向。具体地,固定部6在二维平面平铺开时,固定部6的形状包括但不限于包括半环形、三角形、长方向形,半椭圆形、拱门形。在支架1处于展开三维立体状态时,固定部6为向外张开并向下弯曲形成半环状倒钩的结构(如图3所示)。固定部6在处于张开状态(或释放状态)时,其高度可以为2mm至30mm,宽度可以为2mm至30mm。The bracket has an inflow end 4 and an
在一些实施例中,在支架1的流出端5还设置有多个调整部7,调整部7一端连接支架1,另一端向外张开并向下弯曲呈倒钩状指向支架1外侧壁,或者向外并向上张开。具体地,在调整部7处于完全张开(即完全释放,或者调整线缆已解除)的三维立体状态时,调整部7向外张开并向下弯曲呈倒钩形状指向支架1外侧壁(如图1所示)。在调整部7处于不完全张开(即不完全释放,或者调整线缆未解除)时,调整部7向外并向上张开,且多个调整部7形成喇叭口形状,或者呈花瓣状(如图3所示)。调整部7在二维平面平铺开时,其外形包括但不限于三角形,半环形,方形,长方形,半圆形,半椭圆形,拱门形,调整部在处于不完全张开状态时,其高度可以为2mm至30mm。In some embodiments, the
固定部6和调整部7均为等间隔设置,具体地,固定部6和调整部7可以为沿支架1的流出端5并列且等间隔设置,例如,按固定部6、调整部7、固定部6、调整部7…等重复排列,以环绕支架1的流出端5;也可是按固定部6、调整部7、调整部7、固定部6、调整部7、调整部7、固定部6…等重复排列,以环绕支架1的流出端5;也可以是按调整部7、固定部6、固定部6、调整部7、固定部6、固定部6、…等重复排列,以环绕支架1的流出端5;这些环绕方式可以根据实际应用进行类比调整。当然,固定部6也可以套设调整部7,例如,一个固定部6内套设一个调整部7、一个固定部6内套设两个调整部7、一个固定部6内套设三个调整部7等等以此类推,或者一个调整部7内套设一个固定部7、一个调整部7内套设两个固定部6、一个调整部7内套设三个固定部6等等以此类推。The fixing
参阅附图4,图4示例性示出了支架剖开后的平铺状态,即是将支架1剖开并在二维平面上平铺的状态,如图4所示,固定部6和调整部7的数量相等,固定部6与支架形成封闭的第一网格孔,调整部7与支架形成封闭的第二网格孔,第二网格孔位于第一网格孔之内。更为具体地,流出端5横向设置有12个菱形网格,从而形成12个顶点,每4个连续的顶点形成一个连接区域,每个连接区域内最外侧的两个顶点分别连接同一固定部6,每个连接区域内最内侧的两个顶点分别连接同一调整部7。再者,自流入端4至流出端5的纵向上设置有3个菱形网格,菱形网格相互连接,以形成支架1的本体结构。本实施例中,在支架1处于三维立体空间的张开状态时,调整部7的最高点至固定部6的自由端顶点的垂直距离可以是2mm至30mm。Referring to FIG. 4, FIG. 4 exemplarily shows the tiled state after the bracket is cut, that is, the state in which the
在一些实施例中,调整部7上设置有连接件(未示出),用以连接输送系统的调整线缆8。输送系统即人工瓣膜的输送设备,调整线缆8为输送系统中控制人工瓣膜释放和位置调整的线缆,本实施中为细钢缆。更为具体地,连接件为螺纹孔,在调整线缆8的末端设置与该螺纹孔匹配的螺纹,通过该螺纹孔与调整线缆8螺接;或者连接件为锁扣头,在调整线缆8上设置有与该锁口槽匹配的锁扣槽,基于该锁扣头与该锁口槽进行锁扣连接;或者连接件为锁扣槽,在调整线缆8上设置有与该锁扣槽匹配的锁扣头,通过该锁扣槽与该锁扣头进行锁扣连接。In some embodiments, the adjusting
本发明实施例还提供了一种输送系统,用于受试者心脏主动脉瓣膜的置换,请参阅附图5,图5示例性示出了输送系统的主要结构,如图5所示,输送系统包括可插入受试者主动脉内部的输送管鞘9、设置在输送管鞘9远端的容纳管鞘10以及如上述的经导管主动脉人工瓣膜;其中,经导管主动脉人工瓣膜处于压缩状态,经导管主动脉人工瓣膜的固定部6和调整部7置于输送管鞘9远端的管鞘内,经导管主动脉人工瓣膜的其余部分置于容纳管鞘10内。另外,每个调整部7均通过不同的调整线缆8连接,调整线缆8的另一端伸出输送管鞘9外,便于术者对各个部件进行操作控制。需要说明的是,容纳管鞘9与输送管鞘10可以不直接连接。An embodiment of the present invention also provides a delivery system for the replacement of aortic valve of the heart of a subject, please refer to FIG. 5 , which exemplarily shows the main structure of the delivery system. As shown in FIG. 5 , the delivery The system includes a
请参阅附图5至图8,其示例性展示出输送系统的使用流程,如图所示,在支架1上连接有三个调整部7,每个调整部7上连接一个调整线缆8。将输送系统经外周动脉,优选为股动脉,并将容纳管鞘10输送至主动脉瓣环下进入左心室流出道;通过固定容纳管鞘10,后撤输送管鞘9从而释放固定部6和调整部7;在固定部6张开的过程中,通过微调调整部7对应的调整线缆8,使固定部6精确钩挂在三个主动脉窦11内;待位置调整完毕后,固定输送鞘管9和调整线缆8,前移容纳管鞘10完全释放瓣膜支架进入主动脉瓣区;确定主动脉人工瓣膜的支架1形态、位置合适后,解开调整部7上的调整线缆8,使调整部7完全张开后形成倒钩状,钩挂在原位主动脉瓣膜12上。在人工瓣膜的支架1完全张开后,支架1的外侧壁和固定部6及调整部7形成类似“发夹”结构,共同夹持原位主动脉瓣膜12,防止支架1脱落或移位。Please refer to FIG. 5 to FIG. 8 , which exemplarily show the use process of the delivery system. As shown in the figures, three
本发明实施例还提供了一种输送方法,用于受试者的心脏主动脉瓣膜的置换,输送方法包括:The embodiment of the present invention also provides a delivery method for the replacement of a subject's heart aortic valve, the delivery method comprising:
步骤S1:提供一如上述的输送系统;Step S1: provide the above-mentioned conveying system;
步骤S2:基于输送管鞘9穿经受试者的外周动脉,将容纳管鞘10输送至主动脉瓣环以下,从而进入左心室流出道;Step S2: based on the
步骤S3:固定容纳管鞘10并后撤输送鞘管9,释放固定部6和调整部7,使固定部6向外张开并形成半环状倒钩进入主动脉窦11;Step S3: fixing the
步骤S4:固定输送鞘管9和调整线缆8,前移容纳管鞘10并释放支架1,使支架1展开固定在原位主动脉瓣膜区;Step S4: fix the
步骤S5:进一步释放调整部7,使调整部7张开形成指向支架外侧壁的倒钩以进一步夹持固定原位主动脉瓣12。Step S5 : further release the
下面结合附图和一具体实施例说明本发明提供的输送方法。The conveying method provided by the present invention will be described below with reference to the accompanying drawings and a specific embodiment.
参阅附图9至图12,其示例性示出了输送方法的主要流程:在将输送系统经外周动脉,优选为股动脉,并将容纳鞘管10输送至主动脉瓣环下左心室流出道;通过固定输送系统的内芯13,和调整线缆8,后撤输送管鞘9,释放固定部6和调整部7;使固定部6张开并调整其位置使其精确钩挂进入主动脉窦11内;待位置调整完毕后,通过固定调整线缆8和输送鞘管9,前移容纳鞘管10释放人工瓣膜的支架1;确定人工瓣膜形态、位置合适后,撤掉调整部7上的调整线缆8,使调整部7张开反向勾住原位主动脉瓣膜12;在支架1和固定部6、调整部7完全张开后,支架1的外侧壁和固定部6、调整部7形成类似“发夹”结构,共同夹持原位主动脉瓣膜12,防止支架1脱落或移位。需要说明的是,内芯是贯穿整个输送系统中央的一根细长金属管,为整个系统提供支撑,其它鞘管部件和瓣膜支架均套设在内芯外面;沿径向从里到外依次是:内芯、瓣膜支架、容纳瓣膜支架的鞘管。内芯金属管中间可以使较长的加硬导丝贯穿通过,整个输送系统送入心脏就是先把加硬导丝送入心脏,然后输送系统的内芯套上该加硬导丝顺着送入心脏。Referring to Figures 9 to 12, the main flow of the delivery method is exemplarily shown: after the delivery system is passed through the peripheral artery, preferably the femoral artery, and the receiving
本发明提供的经导管主动脉人工瓣膜,在保证瓣膜支架准确定位的同时,也提供了充足的支撑力和夹持力,防止瓣膜支架移位。The transcatheter aortic artificial valve provided by the present invention not only ensures the accurate positioning of the valve stent, but also provides sufficient supporting force and clamping force to prevent the valve stent from being displaced.
进一步地,设置在支架流出端的固定部为半环形的倒钩结构,其张开后(释放后)钩挂在主动脉窦部以实现人工瓣膜的精准定位和固定,并且固定部、调整部在展开后(释放后)与支架外侧壁相互夹持形成类似“发夹”结构,共同夹持原位主动脉瓣膜,以固定瓣膜支架,防止支架移位。Further, the fixing part arranged on the outflow end of the stent is a semi-annular barb structure, and after it is opened (after releasing), it is hooked on the aortic sinus part to realize the precise positioning and fixing of the artificial valve, and the fixing part and the adjusting part are located in the aortic sinus part. After deployment (after release), it is clamped with the outer side wall of the stent to form a similar "hairpin" structure, which jointly clamps the in-situ aortic valve to fix the valve stent and prevent the stent from shifting.
进一步地,通过调整部可以对支架的位置进行微调,防止初始释放位置的不精确,造成心脏瓣膜置换失败,影响受试者的生命。Further, the position of the stent can be fine-tuned by the adjustment part, so as to prevent the inaccuracy of the initial release position, causing the heart valve replacement failure and affecting the life of the subject.
进一步地,固定部、调整部设置在人工瓣膜支架的流出端,人工瓣膜支架和固定部、调整部完全张开后,支架的外侧壁和固定部、调整部形成类似“发夹”结构,共同夹持原位主动脉瓣膜,防止瓣膜支架脱落或移位,与传统的人工瓣膜相比,利用固定部和调整部进入主动脉窦并共同夹持原位主动脉瓣膜的方式,使瓣膜支架释放更简单精准,位置也更加稳固,由此,在人工瓣膜完全张开的状态下,支架流出端高出主动脉瓣环的部分可以设计的更低,防止高出主动脉瓣环的部分压迫冠状动脉开口,引起其它并发症。Further, the fixing part and the adjusting part are arranged on the outflow end of the artificial valve support, and after the artificial valve support and the fixing part and the adjusting part are fully opened, the outer side wall of the support and the fixing part and the adjusting part form a similar "hairpin" structure, which together Clamp the in-situ aortic valve to prevent the valve stent from falling off or shifting. Compared with the traditional artificial valve, the fixed part and the adjustment part are used to enter the aortic sinus and jointly clamp the in-situ aortic valve to release the valve stent. It is simpler and more precise, and the position is more stable. Therefore, when the prosthetic valve is fully opened, the part of the outflow end of the stent that is higher than the aortic valve annulus can be designed to be lower, preventing the part higher than the aortic valve annulus from compressing the coronary artery. Arterial openings, causing other complications.
需要说明的是,本发明的描述中,“受试者”是个体包括但不限于如动物(例如,人、马、猪、兔、犬、绵羊、山羊、非人灵长类动物、牛、猫、豚鼠或啮齿类动物)、鱼、鸟、爬行动物或两栖动物。所述术语不表示特定的年龄或性别。因此,其也包括成年和新生的受试者以及胎儿(无论雄性或雌性)。It should be noted that, in the description of the present invention, "subject" is an individual including but not limited to animals (eg, humans, horses, pigs, rabbits, dogs, sheep, goats, non-human primates, cattle, cat, guinea pig or rodent), fish, bird, reptile or amphibian. The terms do not denote a specific age or gender. Thus, it also includes adult and neonatal subjects as well as fetuses (whether male or female).
需要说明的是,本发明的描述中,实施例中各种不同元件按适于说明的比例、尺寸、变形量或位移量而描绘,而非按实际元件的比例予以绘制。It should be noted that, in the description of the present invention, various elements in the embodiments are drawn according to the proportion, size, deformation or displacement suitable for the description, rather than the scale of the actual element.
需要说明的是,在本发明的描述中,术语“中心”、“上”、“下”、“左”、“右”、“竖直”、“水平”、“前”、“后”等指示方向或位置关系的术语是基于附图所示的方向或位置关系,这仅仅是为了便于描述,而不是指示或暗示所述装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。此外,术语“第一”、“第二”、“第三”仅用于描述目的,而不能理解为指示或暗示相对重要性。It should be noted that in the description of the present invention, the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "front", "rear", etc. Terms indicating a direction or positional relationship are based on the direction or positional relationship shown in the drawings, which are only for convenience of description, and do not indicate or imply that the device or element must have a particular orientation, be constructed and operate in a particular orientation, Therefore, it should not be construed as a limitation of the present invention. Furthermore, the terms "first", "second", and "third" are used for descriptive purposes only and should not be construed to indicate or imply relative importance.
此外,还需要说明的是,在本发明的描述中,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域技术人员而言,可根据具体情况理解上述术语在本发明中的具体含义。In addition, it should also be noted that, in the description of the present invention, unless otherwise expressly specified and limited, the terms "installed", "connected" and "connected" should be understood in a broad sense, for example, it may be a fixed connection or a It is a detachable connection, or an integral connection; it can be a mechanical connection; it can be directly connected, or it can be indirectly connected through an intermediate medium, and it can be internal communication between two components. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood according to specific situations.
术语“包括”或者任何其它类似用语旨在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备/装置不仅包括那些要素,而且还包括没有明确列出的其它要素,或者还包括这些过程、方法、物品或者设备/装置所固有的要素。The term "comprising" or any other similar term is intended to encompass a non-exclusive inclusion such that a process, method, article or device/means comprising a list of elements includes not only those elements but also other elements not expressly listed, or Also included are elements inherent to these processes, methods, articles or devices/devices.
至此,已经结合附图所示的优选实施方式描述了本发明的技术方案,但是,本领域技术人员容易理解的是,本发明的保护范围显然不局限于这些具体实施方式。在不偏离本发明的原理的前提下,本领域技术人员可以对相关技术特征作出等同的更改或替换,这些更改或替换之后的技术方案都将落入本发明的保护范围之内。So far, the technical solutions of the present invention have been described with reference to the preferred embodiments shown in the accompanying drawings, however, those skilled in the art can easily understand that the protection scope of the present invention is obviously not limited to these specific embodiments. Without departing from the principle of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will fall within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910682854.5A CN111329621A (en) | 2019-07-26 | 2019-07-26 | Transcatheter aortic prosthetic valve, delivery system and delivery method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910682854.5A CN111329621A (en) | 2019-07-26 | 2019-07-26 | Transcatheter aortic prosthetic valve, delivery system and delivery method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111329621A true CN111329621A (en) | 2020-06-26 |
Family
ID=71173763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910682854.5A Pending CN111329621A (en) | 2019-07-26 | 2019-07-26 | Transcatheter aortic prosthetic valve, delivery system and delivery method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111329621A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972067A (en) * | 2021-03-08 | 2021-06-18 | 复旦大学附属中山医院 | Be applied to palirrhea valve support of aortic valve |
| CN113288519A (en) * | 2021-07-01 | 2021-08-24 | 武汉唯柯医疗科技有限公司 | Transcatheter aortic valve device capable of actively capturing valve leaflets |
| CN113440308A (en) * | 2020-07-17 | 2021-09-28 | 宁波健世生物科技有限公司 | Valve prosthesis with variable positioning part and conveying system thereof |
| CN113796988A (en) * | 2020-10-12 | 2021-12-17 | 宁波健世科技股份有限公司 | An adjustable positioning valve delivery system |
| CN114515214A (en) * | 2020-11-20 | 2022-05-20 | 深圳市健心医疗科技有限公司 | Prosthetic valve and prosthetic valve system |
| CN114903653A (en) * | 2022-04-15 | 2022-08-16 | 潘湘斌 | Aortic valve stent and system for delivering aortic valve stent |
| WO2022199172A1 (en) * | 2021-03-26 | 2022-09-29 | 上海申淇医疗科技有限公司 | Artificial heart valve |
| CN115414157A (en) * | 2022-11-07 | 2022-12-02 | 广东捍宇医疗科技有限公司 | Valve device and valve device system |
| CN116407362A (en) * | 2022-04-29 | 2023-07-11 | 武汉唯柯医疗科技有限公司 | A transcatheter aortic valve replacement device with bilateral locking function |
| CN117379227A (en) * | 2022-07-04 | 2024-01-12 | 北京新尖科技有限公司 | Heart valve prosthesis that adaptively avoids native tissue |
| WO2025086923A1 (en) * | 2023-10-25 | 2025-05-01 | 上海臻亿医疗科技有限公司 | Valve stent and artificial valve |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090259306A1 (en) * | 2007-10-15 | 2009-10-15 | Edwards Lifesciences Corporation | Transcatheter heart valve with micro-anchors |
| CN102196784A (en) * | 2008-08-22 | 2011-09-21 | 爱德华兹生命科学公司 | Prosthetic heart valve and delivery apparatus |
| US20110264196A1 (en) * | 2010-04-23 | 2011-10-27 | Medtronic, Inc. | Stents for Prosthetic Heart Valves |
| CN102512271A (en) * | 2011-11-18 | 2012-06-27 | 秦永文 | Transcatheter implantation controllable aortic valvular stent |
| CN103462728A (en) * | 2013-09-13 | 2013-12-25 | 徐州亚太科技有限公司 | Artificial aortic valve support implanted through guide tube and conveying system thereof |
| CN205307151U (en) * | 2016-01-07 | 2016-06-15 | 上海市同济医院 | A atrioventricular valve valve support for $puncturing put into and conveying system thereof |
| CN106890035A (en) * | 2017-04-17 | 2017-06-27 | 乐普(北京)医疗器械股份有限公司 | A transcatheter implantable aortic valve device |
| CN106943207A (en) * | 2016-01-07 | 2017-07-14 | 上海市同济医院 | It is a kind of to be used to puncture the atrioventricular valve valve bracket inserted and its induction system |
| WO2017121194A1 (en) * | 2016-01-11 | 2017-07-20 | 北京迈迪顶峰医疗科技有限公司 | Transcatheter aortic valve device having positioning ring |
| CN107088112A (en) * | 2017-05-18 | 2017-08-25 | 金仕生物科技(常熟)有限公司 | One kind is through conduit aortic valve |
| CN107890382A (en) * | 2017-12-20 | 2018-04-10 | 乐普(北京)医疗器械股份有限公司 | Positionable and retrievable transcatheter implantable aortic valve device |
| CN211156473U (en) * | 2019-07-26 | 2020-08-04 | 闫朝武 | Transcatheter aortic prosthetic valve and delivery system |
-
2019
- 2019-07-26 CN CN201910682854.5A patent/CN111329621A/en active Pending
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090259306A1 (en) * | 2007-10-15 | 2009-10-15 | Edwards Lifesciences Corporation | Transcatheter heart valve with micro-anchors |
| CN102196784A (en) * | 2008-08-22 | 2011-09-21 | 爱德华兹生命科学公司 | Prosthetic heart valve and delivery apparatus |
| US20110264196A1 (en) * | 2010-04-23 | 2011-10-27 | Medtronic, Inc. | Stents for Prosthetic Heart Valves |
| CN102512271A (en) * | 2011-11-18 | 2012-06-27 | 秦永文 | Transcatheter implantation controllable aortic valvular stent |
| CN103462728A (en) * | 2013-09-13 | 2013-12-25 | 徐州亚太科技有限公司 | Artificial aortic valve support implanted through guide tube and conveying system thereof |
| CN205307151U (en) * | 2016-01-07 | 2016-06-15 | 上海市同济医院 | A atrioventricular valve valve support for $puncturing put into and conveying system thereof |
| CN106943207A (en) * | 2016-01-07 | 2017-07-14 | 上海市同济医院 | It is a kind of to be used to puncture the atrioventricular valve valve bracket inserted and its induction system |
| WO2017121194A1 (en) * | 2016-01-11 | 2017-07-20 | 北京迈迪顶峰医疗科技有限公司 | Transcatheter aortic valve device having positioning ring |
| CN106890035A (en) * | 2017-04-17 | 2017-06-27 | 乐普(北京)医疗器械股份有限公司 | A transcatheter implantable aortic valve device |
| CN107088112A (en) * | 2017-05-18 | 2017-08-25 | 金仕生物科技(常熟)有限公司 | One kind is through conduit aortic valve |
| CN107890382A (en) * | 2017-12-20 | 2018-04-10 | 乐普(北京)医疗器械股份有限公司 | Positionable and retrievable transcatheter implantable aortic valve device |
| CN211156473U (en) * | 2019-07-26 | 2020-08-04 | 闫朝武 | Transcatheter aortic prosthetic valve and delivery system |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113440308A (en) * | 2020-07-17 | 2021-09-28 | 宁波健世生物科技有限公司 | Valve prosthesis with variable positioning part and conveying system thereof |
| CN113440308B (en) * | 2020-07-17 | 2025-07-22 | 宁波健世科技股份有限公司 | Valve prosthesis with variable positioning piece and conveying system thereof |
| CN113796988B (en) * | 2020-10-12 | 2025-06-03 | 宁波健世科技股份有限公司 | A valve delivery system with adjustable positioning |
| CN113796988A (en) * | 2020-10-12 | 2021-12-17 | 宁波健世科技股份有限公司 | An adjustable positioning valve delivery system |
| CN114515214A (en) * | 2020-11-20 | 2022-05-20 | 深圳市健心医疗科技有限公司 | Prosthetic valve and prosthetic valve system |
| CN114515214B (en) * | 2020-11-20 | 2025-08-01 | 深圳市健心医疗科技有限公司 | Prosthetic valve and prosthetic valve system |
| CN112972067A (en) * | 2021-03-08 | 2021-06-18 | 复旦大学附属中山医院 | Be applied to palirrhea valve support of aortic valve |
| WO2022199172A1 (en) * | 2021-03-26 | 2022-09-29 | 上海申淇医疗科技有限公司 | Artificial heart valve |
| CN113288519A (en) * | 2021-07-01 | 2021-08-24 | 武汉唯柯医疗科技有限公司 | Transcatheter aortic valve device capable of actively capturing valve leaflets |
| CN114903653A (en) * | 2022-04-15 | 2022-08-16 | 潘湘斌 | Aortic valve stent and system for delivering aortic valve stent |
| CN114903653B (en) * | 2022-04-15 | 2025-07-01 | 潘湘斌 | Aortic valve stent and system for delivering aortic valve stent |
| CN116407362A (en) * | 2022-04-29 | 2023-07-11 | 武汉唯柯医疗科技有限公司 | A transcatheter aortic valve replacement device with bilateral locking function |
| JP2025514440A (en) * | 2022-04-29 | 2025-05-02 | 武漢唯柯医療科技有限公司 | Transcatheter aortic valve replacement device with bilateral locking function |
| CN116407362B (en) * | 2022-04-29 | 2024-09-24 | 武汉唯柯医疗科技有限公司 | Transcatheter aortic valve replacement device with double-side locking function |
| WO2023208236A1 (en) * | 2022-04-29 | 2023-11-02 | 武汉唯柯医疗科技有限公司 | Transcatheter aortic valve replacement apparatus having bilateral locking function |
| CN117379227A (en) * | 2022-07-04 | 2024-01-12 | 北京新尖科技有限公司 | Heart valve prosthesis that adaptively avoids native tissue |
| CN115414157A (en) * | 2022-11-07 | 2022-12-02 | 广东捍宇医疗科技有限公司 | Valve device and valve device system |
| WO2025086923A1 (en) * | 2023-10-25 | 2025-05-01 | 上海臻亿医疗科技有限公司 | Valve stent and artificial valve |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111329621A (en) | Transcatheter aortic prosthetic valve, delivery system and delivery method | |
| US10363131B2 (en) | Aortic insufficiency valve percutaneous valve anchoring | |
| JP5250046B2 (en) | Percutaneous heart valve, system, and method | |
| AU2015221440B2 (en) | A replacement valve | |
| US8137398B2 (en) | Prosthetic valve having tapered tip when compressed for delivery | |
| CN105658180B (en) | Modularization valve prosthesis with anchor support and valving members | |
| EP2953578B1 (en) | Peripheral sealing venous check-valve | |
| EP3528749A1 (en) | Stent of aortic valve implanted transcatheterly | |
| AU2020420975B2 (en) | Structurally fitted transcatheter aortic valve implantation device | |
| US20140309680A1 (en) | Insertion device, in particular a catheter, for inserting a medical hybrid implant, and also medical hybrid implant to be inserted by means of an insertion device | |
| AU2022392685A1 (en) | Split-type interventional tricuspid valve system capable of accurately anchoring | |
| CN105287051A (en) | Artificial aortic valve ring system implanted through peripheral arterial approach | |
| CN211156473U (en) | Transcatheter aortic prosthetic valve and delivery system | |
| WO2024139172A1 (en) | Valve frame, valve frame assembly, heart valve prosthesis, and heart valve prosthesis system | |
| US20250032252A1 (en) | Split type precisely-anchorable interventional aortic valve system | |
| CN114173709A (en) | Transcatheter heart valve and method to reduce leaflet thrombosis | |
| EP4282381A1 (en) | Implant delivery apparatus and implant delivery system | |
| CN205339217U (en) | Carry aortic valve valve device through pipe | |
| CN217987801U (en) | Implant conveying device and implant conveying system | |
| WO2021016750A1 (en) | Transcatheter aortic prosthetic valve, delivery system, and delivery method | |
| CN222055685U (en) | Artificial valve device | |
| CN118319557B (en) | A fixation ring, an artificial heart valve stent system, and a release method thereof. | |
| CN116687622A (en) | Self-expanding tricuspid valve metal stent, tricuspid valve intervention valve, implantation system and manufacturing method | |
| CN120284535A (en) | Valve stents and valve prostheses | |
| Hashimoto et al. | Development of a Re‐Positionable Aortic Stent‐Valve: A Preliminary Study in Swine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200626 |